Skip to content

Formula Tolerance of Term Infants

Tolerance of Term Infants Fed Formula With Oligosaccharides

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04915937
Enrollment
45
Registered
2021-06-07
Start date
2021-07-13
Completion date
2022-11-22
Last updated
2022-12-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gastro-Intestinal Tolerance

Brief summary

To assess the effects of infant formula with oligosaccharides on symptoms of formula intolerance in healthy, term infants

Interventions

RTF milk-based infant formula with oligosaccharides

Sponsors

Abbott Nutrition
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
7 Days to 65 Days
Healthy volunteers
Yes

Inclusion criteria

* Participant is judged to be in good health as determined from participant's medical history by parent report * Participant is a singleton from a full-term birth with a gestational age of 37-42 weeks. * Participant's birth weight was \>= 2490 g (\ 5 lbs. 8 oz.) * Participant was identified by parents as very fussy or extremely fussy in the Baseline Tolerance Evaluation on a formula-feed * Participant is exclusively formula-fed at time of study entry and Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study, unless instructed otherwise by their healthcare professional. * Parent(s) confirm their intention not to administer vitamin, mineral, human milk oligosaccharide(s) (HMO), prebiotic(s), or probiotic(s) supplements (with the exception of vitamin D supplements if instructed by their healthcare professional), non-study formula, foods, juices, or other sources of nutrition to their infant from enrollment through the duration of the study * Participant's parent(s) has voluntarily signed and dated an Informed Consent Form (ICF), approved by an Institutional Review Board/Independent Ethics Committee (IRB/IEC) and provided applicable local privacy regulation authorization prior to any participation in the study

Exclusion criteria

* An adverse maternal, fetal, or participant medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development. This includes but is not limited to suspected maternal substance abuse. * Participant is taking and plans to continue taking medications (including OTC, such as Mylicon® for gas), home remedies (such as juice for constipation), herbal preparations, or rehydration fluids that might affect GI tolerance. * Participant participates in another study that has not been approved as a concomitant study * Participant has been fed a formula with greater than 2 HMOs prior to study enrollment * Participant has been fed an extensively hydrolyzed, amino acid based, or preterm formula within 14 days prior to study enrollment and/or an extensively hydrolyzed, amino acid based, or preterm formula has been recommended by the physician. * Participant has an allergy or intolerance to any ingredient in the study product, as reported by the parent * Participant has been treated with antibiotics within 7 days prior to enrollment

Design outcomes

Primary

MeasureTime frameDescription
FussinessBaseline to Study Day (SDAY) 2Absolute and % change in fussiness severity reported from Daily Tolerance Diary

Secondary

MeasureTime frameDescription
Gastrointestinal ToleranceBaseline to SDAY 28Parent Completed Diary
StoolBaseline to SDAY 28Parent Completed Diary

Other

MeasureTime frameDescription
LengthSDAY 1 to SDAY 28Length gains, percentiles, and z-scores
Infant Feeding and Stool Patterns QuestionnaireSDAY 1 and SDAY 28Parent completed questionnaire; 16, 5-point Likert scale questions, scaled from frequent to less frequent
Adverse EventsSDAY 1 to SDAY 28Standard adverse event reporting
Parental perspectivesSDAY 1 and SDAY 28Parent completed questionnaire; 4, 5-point Likert scale questions, scaled from negative to positive
Health Resource UtilizationSDAY 7 and SDAY 28Number of Visits
Formula Satisfaction QuestionnaireSDAY 1 and SDAY 28Parent completed questionnaire; 13 questions of up to 5 categories scaled from positive to negative
Formula IntakeSDAY 1 to SDAY 28Parent Completed Diary
WeightSDAY 1 to SDAY 28Weight gains, percentiles, and z-scores

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026